Top Stories

U.S. states face steep decline in J&J vaccine


Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021.

Dado Ruvic | Reuters

Johnson & Johnson is scaling back shipments of its single-dose Covid-19 vaccine by 86% next week as it grapples with manufacturing issues at a major plant in Baltimore.

The government has allocated only 700,000 J&J shots to states next week, down from 4.9 million the week prior, according to data from the Centers for Disease Control and Prevention.

J&J is awaiting regulatory clearance for a Baltimore facility, which is run by Emergent BioSolutions Inc, and is working with the U.S. Food and Drug Administration to…


GameStop, Costco, Box, Constellation Brands & more

Previous article

Senate Banking Committee Chair Brown targets banks ties to Archegos

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories